These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9242544)

  • 1. N-acetyl-L-cysteine exhibits antitumoral activity by increasing tumor necrosis factor alpha-dependent T-cell cytotoxicity.
    Delneste Y; Jeannin P; Potier L; Romero P; Bonnefoy JY
    Blood; 1997 Aug; 90(3):1124-32. PubMed ID: 9242544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promotion of murine antitumor activity by prothymosin alpha treatment: I. Induction of tumoricidal peritoneal cells producing high levels of tumour necrosis factor alpha.
    Papanastasiou M; Baxevanis CN; Papamichail M
    Cancer Immunol Immunother; 1992; 35(2):145-50. PubMed ID: 1596938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and decreased TNF-alpha gene expression.
    Kalinichenko VV; Mokyr MB; Graf LH; Cohen RL; Chambers DA
    J Immunol; 1999 Sep; 163(5):2492-9. PubMed ID: 10452985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased T cell cytotoxicity by Betathine-induced upregulation of TNFalpha.
    Dunn TM; Wormsley S; Taub FE; Pontzer CH
    Int J Immunopharmacol; 2000 Mar; 22(3):213-27. PubMed ID: 10685004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide and its analogues have distinct and opposing effects on TNF-alpha and TNFR2 during co-stimulation of both CD4(+) and CD8(+) T cells.
    Marriott JB; Clarke IA; Dredge K; Muller G; Stirling D; Dalgleish AG
    Clin Exp Immunol; 2002 Oct; 130(1):75-84. PubMed ID: 12296856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-derived recognition factor (TDRF) induces production of TNF-alpha by murine macrophages, but requires synergy with IFN-gamma alone or in combination with IL-2 to induce nitric oxide synthase.
    Jiang H; Stewart CA; Fast DJ; Leu RW
    Int J Immunopharmacol; 1996; 18(8-9):479-90. PubMed ID: 9023587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and regulation of tumor necrosis factor, interleukin-2, and hematopoietic growth factor receptors in B-cell chronic lymphocytic leukemia.
    Trentin L; Zambello R; Agostini C; Enthammer C; Cerutti A; Adami F; Zamboni S; Semenzato G
    Blood; 1994 Dec; 84(12):4249-56. PubMed ID: 7994039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming tumor necrosis factor-alpha resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-alpha. Role of tumor necrosis factor-alpha mRNA down-regulation in tumor cell sensitization.
    Mizutani Y; Yoshida O
    Cancer; 1994 Feb; 73(3):730-7. PubMed ID: 8299097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-derived factor synergizes with IFN-gamma and LPS, IL-2 or TNF-alpha to promote macrophage synthesis of TNF-alpha and TNF receptors for autocrine induction of nitric oxide synthase and enhanced nitric oxide-mediated tumor cytotoxicity.
    Jiang H; Stewart CA; Leu RW
    Immunobiology; 1995 Apr; 192(5):321-42. PubMed ID: 7544321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylcysteine inhibits TNF-alpha, sTNFR, and TGF-beta1 release by alveolar macrophages in idiopathic pulmonary fibrosis in vitro.
    Cu A; Ye Q; Sarria R; Nakamura S; Guzman J; Costabel U
    Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(2):147-54. PubMed ID: 20560295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity.
    Owen-Schaub LB; Gutterman JU; Grimm EA
    Cancer Res; 1988 Feb; 48(4):788-92. PubMed ID: 3257408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of TNF production for the curative effectiveness of low dose melphalan therapy for mice bearing a large MOPC-315 tumor.
    Gorelik L; Rubin M; Prokhorova A; Mokyr MB
    J Immunol; 1995 Apr; 154(8):3941-51. PubMed ID: 7706732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced murine macrophage TNF receptor shedding by cytosine-guanine sequences in oligodeoxynucleotides.
    Jin L; Raymond DP; Crabtree TD; Pelletier SJ; Houlgrave CW; Pruett TL; Sawyer RG
    J Immunol; 2000 Nov; 165(9):5153-60. PubMed ID: 11046047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tumor necrosis factor alpha in hyperthermia-induced apoptosis of human leukemia cells.
    Katschinski DM; Robins HI; Schad M; Frede S; Fandrey J
    Cancer Res; 1999 Jul; 59(14):3404-10. PubMed ID: 10416602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor alpha (TNF-alpha) and TNF-beta and their receptors in experimental cutaneous leishmaniasis.
    de Kossodo S; Grau GE; Louis JA; Müller I
    Infect Immun; 1994 Apr; 62(4):1414-20. PubMed ID: 8132347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deferasirox shows in vitro and in vivo antileukemic effects on murine leukemic cell lines regardless of iron status.
    Lee DH; Jang PS; Chung NG; Cho B; Jeong DC; Kim HK
    Exp Hematol; 2013 Jun; 41(6):539-46. PubMed ID: 23415674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitization of immunoresistant prostate carcinoma cell lines to Fas/Fas ligand-mediated killing by cytotoxic lymphocytes: independence of de novo protein synthesis.
    Frost PJ; Belldegrun A; Bonavida B
    Prostate; 1999 Sep; 41(1):20-30. PubMed ID: 10440872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional regulation of the biological effects of TNF-alpha by the soluble type I and type II TNF receptors.
    Hale KK; Smith CG; Baker SL; Vanderslice RW; Squires CH; Gleason TM; Tucker KK; Kohno T; Russell DA
    Cytokine; 1995 Jan; 7(1):26-38. PubMed ID: 7749064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of antitumor CTL response by GM-CSF involves a B7-dependent mechanism.
    Mokyr MB; Kalinichenko TV; Gorelik L
    Cell Immunol; 1997 Jun; 178(2):152-61. PubMed ID: 9225006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of the generation of cytotoxic T lymphocytes against syngeneic tumor cells by recombinant human tumor necrosis factor.
    Nakano K; Okugawa K; Furuichi H; Matsui Y; Sohmura Y
    Cell Immunol; 1989 Apr; 120(1):154-64. PubMed ID: 2649256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.